ea0065p31 | Adrenal and Cardiovascular | SFEBES2019
Gohil Shailesh
, Seehra Jaspreet
, Chauhan Vishnusai
, Richards Catherine
, Lloyd David
, Bhake Ragini
, Bhardwaj Neil
, Levy Miles
Background: The phaeochromocytoma of the adrenal gland scaled score (PASS) is used for histological reporting of phaeochromocytomas as a surrogate marker of malignant potential. A PASS score of ≥4 (of a maximum of 20) suggests an aggressive tumour and hence the importance of lifelong careful follow-up. However, the utility of the PASS score has been questioned recently due to the discordance between PASS score and clinical outcomes.Aim: To review t...